Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
P antigen family, member 4 pseudogene (PAGE4 pseudogene) is a processed pseudogene, meaning it originated from retrotransposition of mRNA and is generally non-functional due to mutations that prevent normal transcription or translation. This pseudogene does not encode an active protein, does not serve as a therapeutic target, and has no documented role in disease processes[1][2][6]. While some pseudogenes in other contexts can regulate gene expression or act as decoys in gene regulation networks, there is no evidence that this specific pseudogene, ENSG00000235349, is biologically active or therapeutically relevant[1][2][3][6]. The functional PAGE4 gene (distinct from this pseudogene) is part of the GAGE cancer-testis antigen family, associated with reproductive tissues and prostate/testicular cancers[5][7].\n\nIf you are seeking actionable or therapeutic information, you should refer to the canonical PAGE4 gene (Ensembl ID: ENSG00000101951), not this pseudogene[5][7].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P antigen family, member 4 pseudogene (PAGE4 pseudogene).